Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Annual Information Update

27 May 2008 07:00

RNS Number : 2033V
PuriCore Plc
27 May 2008
 



Annual Information Update

27 May 2008: In accordance with Prospectus Rule 5.2, PuriCore (LSE: PURI), the life sciences company focused on the development and commercialisation of its novel, safe antimicrobial technology, sets out below a list of the information that has been published or made available to the public over the previous twelve months, up to and including 29 May 2008.

The information referred to in this Annual Information Update was up-to-date at the time it was published but such disclosures may now be or may at any time become out-of-date due to changing circumstances.

 

 

1. Announcements made via the Regulatory Information Service

All the announcements listed below can be obtained from the London Stock Exchange website, www.longonstockexchange.com/marketnews or from the Company's website, www.puricore.com

 

 

Date

Headline

14/05/2007

PuriCore plc - Annual Information Update

31/05/2007

PuriCore plc - Results of AGM

11/06/2007

PuriCore plc -  Presenting Conference

11/06/2007

PuriCore plc - Holding(s) in Company

23/07/2007

PuriCore plc - Trading Update

24/07/2007

PuriCore plc - Holding(s) in Company

24/07/2007

PuriCore plc - Director's Interest

31/08/2007

PuriCore plc - Blocklisting Interim Review

04/09/2007

PuriCore plc - Blocklisting Applications

05/09/2007

PuriCore plc - Holding(s) in Company

24/09/2007

PuriCore plc - Interim Results

08/10/2007

PuriCore plc - Receives US Patent 

12/10/2007

PuriCore plc - FCSI Product of the Year

17/10/2007

PuriCore plc - Arranges Borrowing Facility

25/10/2007

PuriCore plc - Presenting at Conference

23/11/2007

PuriCore plc - Holding(s) in Company

10/12/2007

PuriCore plc - Additional US Patent 

12/12/2007

PuriCore plc - Adds Five Supermarket Chains

21/12/2007

PuriCore plc - Holding(s) in Company

11/01/2008

PuriCore plc - Food Retail Contract

23/01/2008

PuriCore plc - Research Update

01/02/2008

PuriCore plc - Voting Rights 

06/02/2008

PuriCore plc - Blocklisting Interim Review

06/02/2008

PuriCore plc - Senior Independent Director

08/02/2008

PuriCore plc - Holding(s) in Company

20/02/2008

PuriCore plc - Acquisition Agreement for IP

20/02/2008

PuriCore plc - Trading Update

21/02/2008

PuriCore plc - Director/PDMR Shareholding

21/02/2008

PuriCore plc - Notice of Interest in Shares

03/04/2008

PuriCore plc - Notice of Results

29/04/2008

PuriCore plc - Final Results

29/04/2008

PuriCore plc - Interim Management Statement

30/04/2008

PuriCore plc - Director/PDMR Shareholding

01/05/2008

PuriCore plc - Director/PDMR Shareholding

13/05/2008

PuriCore plc - Director/PDMR Shareholding

14/05/2008

PuriCore plc - Holding(s) in Company

20/05/2008

PuriCore plc - Holding(s) in Company

2. Documents filed at Companies House

Copies of these documents can be obtained from Companies House at Crown Way, Maindy, Cardiff CF14 3UZ or from Companies House website www.companieshouse.co.uk

23/05/2008

363a

23/05/2008

353

16/05/2008

88(2)

06/08/2007

AA

10/07/2007

RES 11

3. Documents published and sent to shareholders

NONE

4. Documents Filed with the UKLA Documents Viewing Facility

 

 

Date

Document Description

22/05/2008

Half-Yearly Report 2007

22/05/2008

Preliminary Results 2008

Copies of these documents can be obtained from the CRO at:

 

Companies Registration Office

UK Address

 

In accordance with Article 27(3) of the Prospectus Directive Regulations, it is acknowledged that whilst the information referred to above was up to date at the time of publication, such disclosures may, at any time, become out of date due to changing circumstances.

 

Andrea Holtzman Drucker

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUZGGZKDFMGRZM
Date   Source Headline
9th Oct 20185:02 pmRNSForm 8.3 - Realm Therapeutics PLC
9th Oct 201810:13 amRNSForm 8.3 - Realm Therapeutics plc
5th Oct 20186:08 pmBUSForm 8.3 - Realm Therapeutics PLC
5th Oct 20182:00 pmRNSFORM 8.3 - Realm Therapeutics Plc
4th Oct 20188:57 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics plc
2nd Oct 201810:43 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics PLC
1st Oct 20187:00 amRNSProvides Update on Timing of Formal Sale Process
24th Sep 20189:59 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
21st Sep 201811:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Sep 20185:06 pmRNSForm 8.3 - Realm Therapeutics plc
20th Sep 20185:06 pmRNSForm 8.3 - Realm Therapeutics plc
20th Sep 20183:16 pmRNSHolding(s) in Company
20th Sep 201811:53 amRNSForm 8.3 - REALM THERAPEUTICS PLC
20th Sep 201811:18 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
19th Sep 20184:31 pmRNSForm 8 (OPD) - Realm Therapeutics plc
19th Sep 201811:11 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
18th Sep 201811:19 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
17th Sep 20187:00 amRNSCorporate Update and Hiring of Advisor
20th Aug 201811:00 amRNSPrice Monitoring Extension
20th Aug 20187:00 amRNSBlock listing Interim Review
15th Aug 20184:35 pmRNSPrice Monitoring Extension
14th Aug 20187:10 amRNSHalf-year Report
8th Aug 20187:00 amRNSPresents at Wedbush PacGrow Healthcare Conference
7th Aug 20187:00 amRNSNotice of Results
16th Jul 20185:33 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPre-Clinical Study in Atopic Dermatitis
4th Jul 20187:00 amRNSInstructions for Exchanging Ordinary Shares
4th Jul 20187:00 amRNSSEC registration effective NASDAQ listing approved
14th Jun 201810:54 amRNSResult of AGM
31st May 20187:00 amRNSRealm to Present at June Investor Conferences
24th May 20187:00 amRNSEnrollment complete for Phase 2 study of PR022
23rd May 20187:00 amRNSFiling with US SEC to Facilitate Nasdaq Listing
21st May 20187:00 amRNSData Presentation at IID 2018
2nd May 201812:39 pmRNSAnnual Financial Report Available
2nd May 20187:00 amRNSFinal Results
2nd May 20187:00 amRNSRealm Files Registration for Nasdaq Listing of ADS
26th Apr 20182:32 pmRNSNotice of Results
12th Mar 20184:40 pmRNSSecond Price Monitoring Extn
12th Mar 20184:35 pmRNSPrice Monitoring Extension
12th Mar 20187:00 amRNSClinical Update including PR013 Phase II results
8th Mar 20187:00 amRNSPresenting at Cowen Healthcare Conference
27th Feb 20187:00 amRNSPatent portfolio strengthened with USPTO allowance
20th Feb 201812:00 pmRNSPresentation at RBC Healthcare Conference
16th Feb 20187:00 amRNSBlock listing Interim Review
15th Feb 20187:00 amRNSClinical and Business Update
2nd Jan 20187:00 amRNSPresents at 5th Annual Dermatology Summit
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSFirst Patient Dosed in Phase 2 Study of PR013
5th Dec 20177:00 amRNSFirst Patient Dosed in Phase 2 Study of PR022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.